EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism

Chen Ye, Wen Jiang, Ting Hu, Jichao Liang, Yong Chen

International Journal of Molecular Sciences · 19.07.2024 · 25 (14) · 7897

DOI: 10.3390/ijms25147897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.07.2024. Verfasst von Chen Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: National & Local Joint Engineering Research Center of High throughput Drug Screening Technology, Hubei Province Key Laboratory of Biotechnology of Ch…. Hauptthemen laut MEDLINE: Hepatocytes, Lipid Metabolism, Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) has emerged as the leading cause of chronic liver disease worldwide. Caspase 8 and FADD-like apoptosis regulator (CFLAR) has been identified as a potent factor in mitigating non-alcoholic steatohepatitis (NASH) by inhibiting the N-terminal dimerization of apoptosis signal-regulating kinase 1 (ASK1). While arginine methyltransferase 1 (PRMT1) was previously reported to be associated with increased hepatic glucose production, its involvement in hepatic lipid metabolism remains largely unexplored. The interaction between PRMT1 and CFLAR and the methylation of CFLAR were verified by Co-IP and immunoblotting assays. Recombinant adenoviruses were generated for overexpression or knockdown of PRMT1 in hepatocytes. The role of PRMT1 in NAFLD was investigated in normal and high-fat diet-induced obese mice. In this study, we found a significant upregulation of PRMT1 and downregulation of CFLAR after 48h of fasting, while the latter significantly rebounded after 12h of refeeding. The expression of PRMT1 increased in the livers of mice fed a methionine choline-deficient (MCD) diet and in hepatocytes challenged with oleic acid (OA)/palmitic acid (PA). Overexpression of PRMT1 not only inhibited the expression of genes involved in fatty acid oxidation (FAO) and promoted the expression of genes involved in fatty acid synthesis (FAS), resulting in increased triglyceride accumulation in primary hepatocytes, but also enhanced the gluconeogenesis of primary hepatocytes. Conversely, knockdown of hepatic PRMT1 significantly alleviated MCD diet-induced hepatic lipid metabolism abnormalities and liver injury in vivo, possibly through the upregulation of CFLAR protein levels. Knockdown of PRMT1 suppressed the expression of genes related to FAS and enhanced the expression of genes involved in FAO, causing decreased triglyceride accumulation in OA/PA-treated primary hepatocytes in vitro. Although short-term overexpression of PRMT1 had no significant effect on hepatic triglyceride levels under physiological conditions, it resulted in increased serum triglyceride and fasting blood glucose levels in normal C57BL/6J mice. More importantly, PRMT1 was observed to interact with and methylate CFLAR, ultimately leading to its ubiquitination-mediated protein degradation. This process subsequently triggered the activation of c-Jun N-terminal kinase 1 (JNK1) and lipid deposition in primary hepatocytes. Together, these results suggested that PRMT1-mediated methylation of CFLAR plays a critical role in hepatic lipid metabolism. Targeting PRMT1 for drug design may represent a promising strategy for the treatment of NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesLipid MetabolismLiverNon-alcoholic Fatty Liver DiseaseProtein-Arginine N-MethyltransferasesAnimalsHumansMaleMiceApoptosis Regulatory ProteinsDiet, High-FatMethylationMice, Inbred C57BLCASP8 and FADD-Like Apoptosis Regulating Protein

Stichwörter der Autor:innen

CFLARNAFLDPRMT1lipid accumulationmethylationpJNK1

Substanzen

Apoptosis Regulatory ProteinsProtein-Arginine N-MethyltransferasesPrmt1 protein, mouseCflar protein, mouseCASP8 and FADD-Like Apoptosis Regulating Protein

Autor:innen und Institutionen

  • National & Local Joint Engineering Research Center of High throughput Drug Screening Technology, Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering,…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ye, C., Jiang, W., Hu, T., Liang, J., & Chen, Y. (2024). The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism. International Journal of Molecular Sciences, 25(14), 7897. https://doi.org/10.3390/ijms25147897

Vancouver

Ye C, Jiang W, Hu T, Liang J, Chen Y. The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism. International Journal of Molecular Sciences. 2024;25(14):7897. doi:10.3390/ijms25147897

BibTeX
@article{Ye2024,
  author = {Ye, Chen and Jiang, Wen and Hu, Ting and Liang, Jichao and Chen, Yong},
  title = {The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {14},
  pages = {7897},
  doi = {10.3390/ijms25147897}
}
Kostenlos starten →